Medifast [MED] vs Regis [RGS] Detailed Stock Comparison

Medifast Inc.

NYSE
Loading...

Regis Corporation

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Medifast Inc. wins in 3 metrics, Regis Corporation wins in 16 metrics, with 0 ties. Regis Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Medifast Inc. Regis Corporation Better
P/E Ratio (TTM) 531.50 0.61 Regis Corporation
Price-to-Book Ratio 0.57 0.37 Regis Corporation
Debt-to-Equity Ratio 5.38 182.32 Medifast Inc.
PEG Ratio -0.22 -0.01 Regis Corporation
EV/EBITDA -1,469.18 14.73 Regis Corporation
Profit Margin (TTM) -4.84% 50.79% Regis Corporation
Operating Margin (TTM) -10.39% 10.85% Regis Corporation
EBITDA Margin (TTM) N/A 10.85% N/A
Return on Equity -9.13% 94.31% Regis Corporation
Return on Assets (TTM) -3.34% 2.60% Regis Corporation
Free Cash Flow (TTM) $1.25M $12.45M Regis Corporation
1-Year Return -10.95% 29.78% Regis Corporation
Price-to-Sales Ratio (TTM) 0.32 0.30 Regis Corporation
Enterprise Value $-42.61M $394.59M Regis Corporation
EV/Revenue Ratio -0.11 1.69 Regis Corporation
Gross Profit Margin (TTM) 69.43% 36.51% Medifast Inc.
Revenue per Share (TTM) $35 $96 Regis Corporation
Earnings per Share (Diluted) $-1.70 $44.99 Regis Corporation
Beta (Stock Volatility) 0.56 1.40 Medifast Inc.
Short % of Float 19.31% 2.55% Regis Corporation

Medifast Inc. vs Regis Corporation Stock Performance Analysis

Loading Price Chart...

MED
RGS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Medifast Inc.0.25%-6.69%15.43%14.57%12.98%17.98%
Regis Corporation1.67%-5.83%3.23%23.32%-5.15%2.66%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Medifast Inc.-10.95%-85.01%-95.99%-61.95%-51.02%-36.36%
Regis Corporation29.78%28.36%-84.83%-88.92%97.62%-19.75%

Performance & Financial Health Analysis: Medifast Inc. vs Regis Corporation

MetricMEDRGS
Market Information
Market Cap i$121.13M$67.69M
Market Cap CategoryMicro capMicro cap
10 Day Avg. Volume i240,38712,344
90 Day Avg. Volume i275,59210,715
Last Close$12.27$27.45
52 Week Range$9.22 - $15.46$18.20 - $31.50
% from 52W High-20.63%-12.86%
All-Time High$336.99 (May 24, 2021)$465.40 (Oct 28, 2019)
% from All-Time High-96.36%-94.10%
Growth Metrics
Quarterly Revenue Growth-0.37%0.22%
Quarterly Earnings Growth-0.37%-0.94%
Financial Health
Profit Margin (TTM) i-0.05%0.51%
Operating Margin (TTM) i-0.10%0.11%
Return on Equity (TTM) i-0.09%0.94%
Debt to Equity (MRQ) i5.38182.32
Cash & Liquidity
Book Value per Share (MRQ)$19.29$75.52
Cash per Share (MRQ)$16.22$7.36
Operating Cash Flow (TTM) i$6.86M$16.90M
Levered Free Cash Flow (TTM) i$5.41M$6.72M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00$0.00

Valuation & Enterprise Metrics Analysis: Medifast Inc. vs Regis Corporation

MetricMED (Apr 24, 2026)RGS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i531.500.61
Forward P/E i-4.00-10.45
PEG Ratio i-0.22-0.01
Price to Sales (TTM) i0.320.30
Price to Book (MRQ) i0.570.37
Market Capitalization
Market Capitalization i$121.13M$67.69M
Enterprise Value i$-42,606,284$394.59M
Enterprise Value Metrics
Enterprise to Revenue i-0.111.69
Enterprise to EBITDA i-1,469.1814.73
Risk & Other Metrics
Beta i0.561.40
Book Value per Share (MRQ) i$19.29$75.52

Financial Statements Comparison: Medifast Inc. vs Regis Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMED (2025)RGS (2025)
Revenue/Sales i385.79M210.13M
Cost of Goods Sold i110.60M129.63M
COGS % of Revenue i28.7%61.7%
Gross Profit i275.19M80.51M
Gross Margin i71.3%38.3%
Research & Development iN/AN/A
Operating Income (EBIT) i-14.21M20.29M
Operating Margin i-3.7%9.7%
EBITDA i29,00025.11M
EBITDA Margin i0.0%11.9%
Pre-Tax Income i-5.64M1.54M
Pre-Tax Income % of Revenue i-1.5%0.7%
Income Tax i13.03M-115.50M
Income Tax % of Revenue i3.4%-55.0%
Net Income (Profit) i-18.67M123.54M
Profit Margin i-4.8%58.8%

Balance Sheet & Liquidity Metrics

MetricMED (2025)RGS (2025)
Cash & Equivalents i89.30M16.96M
Total Current Assets i201.68M50.48M
Total Current Assets % of Revenue i52.3%24.0%
Total Current Liabilities i42.96M101.69M
Total Current Liabilities % of Revenue i11.1%48.4%
Long-Term Debt iN/A288.97M
Long-Term Debt % of Revenue i0.0%137.5%
Total Shareholders Equity i198.92M185.62M
Retained Earnings i158.27M101.97M
Retained Earnings % of Revenue i41.0%48.5%
Property, Plant & Equipment i7.23M229.86M

Cash Flow Statement Comparison

MetricMED (2025)RGS (2025)
Operating Cash Flow i8.92M27.08M
Operating Cash Flow % of Revenue i2.3%12.9%
Capital Expenditures i-5.61MN/A
Free Cash Flow i1.25M12.45M
FCF Margin i0.3%5.9%
Debt Repayment iN/A-14.66M
Common Stock Repurchase i-369,000N/A

Short Interest & Institutional Ownership Analysis

MetricMEDRGS
Shares Short i2.06M54,561
Short Ratio i7.145.89
Short % of Float i19.31%2.55%
Shares Outstanding i10.99M2.50M
Float Shares i8.48M2.38M
% Held by Insiders i3.86%15.13%
% Held by Institutions i78.14%30.81%
% Held by Public i18.00%54.06%

Dividend Analysis & Yield Comparison: Medifast Inc. vs Regis Corporation

MetricMEDRGS
Last 12-Month Dividend i$0.00$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$2.74$0.00
3-Year Avg Dividend Yield i1.43%N/A
3-Year Total Dividends i$8.22$0.00
Ex-Dividend DateJun 26, 2023N/A